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The ubiquitous second messenger cGMP is synthesized by guanylyl cyclase and
hydrolyzed by phosphodiesterase (PDE). cGMP mediates numerous signaling pathways in
multiple tissues. In the retina, cGMP regulates signaling in nearly every cell class including
photoreceptors, bipolar cells, amacrine cells, and ganglion cells. In order to understand the
specific role of cGMP and its regulating enzymes in different cell types, it is first necessary
to localize these components and dissect their influence on the circuits. Here we tested
the contribution of PDE9A to retinal processing by recording the electroretinograms (ERG)
of PDE9A−/− (KO) mice and by localizing the enzyme. We found that while the scotopic
ERG of KO was the same as that of wild type (WT) in both amplitude and kinetics, the
photopic ERG was greatly affected. The greatest effect was on the recovery of the b-wave;
the falling phase and the b-wave duration were significantly longer in the KO mice for all
photopic stimuli (UV, green, or saturating white flashes). The rising phase was slower in
KO than in WT for UV and green stimuli. For certain stimuli, amplitudes of both the a- and
b-waves were smaller than in WT. Using Lac-Z expression in KO retinas as a reporter
for PDE9A expression pattern, we found that PDE9A is localized to GABA-positive and
GABA-negative amacrine cells, and likely also to certain types of ganglion cells. Our results
indicate that PDE9A, by controlling the level of cGMP, modulates inhibitory processes
within the cone pathway. We speculate that these circuits involve NO/cGMP signaling
pathways.
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INTRODUCTION
The ubiquitous second messenger cGMP, which is synthesized
by guanylyl cyclases (GC) and hydrolyzed by phospodiesterases
(PDE), controls a variety of processes from smooth muscle cell
contraction in the vasculature to signaling in the central ner-
vous system (Beavo, 1995; Polson and Strada, 1996; Juilfs et al.,
1999). cGMP typically accomplishes these functions either by
gating cyclic nucleotide-gated (CNG) channels or by activating
cGMP-dependent kinases and phosphatases. In the retina, cGMP
regulates nearly every step of signal processing. At the first step
of retinal processing, rod and cone photoreceptors use cGMP to
gate CNG channels. In these cells, light activates PDE6, which
hydrolyzes cGMP; this closes the CNG channels and the cells
hyperpolarize (Lamb and Pugh, 1992; Hsu and Molday, 1993;
Yau, 1994). At the next step of retinal processing, ON bipolar
cells (rod bipolar that mediate night vision and ON cone bipo-
lar cells that signal light increments in daylight vision) appear
to use cGMP, but its function is still unclear. cGMP was ini-
tially thought to gate a CNG channel similar to photoreceptors
(Nawy and Jahr, 1990; Shiells and Falk, 1990, 1992; de la Villa
et al., 1995). It is now known that ON bipolar cells use the non-
selective cation channel TRPM1, which is not gated by cGMP
(Morgans et al., 2009; Koike et al., 2010). Instead, some evidence
suggests that cGMP potentiates the light response at low light
intensities (Nawy, 1999; Shiells and Falk, 2002; Snellman and
Nawy, 2004). At the next stage of visual processing, some third
order neurons (including certain types of amacrine and ganglion
cells) modulate cGMP, often in response to NO (Ahmad et al.,
1994; Gotzes et al., 1998; Chun et al., 1999; Blute et al., 2003).
The NO/cGMP pathway is also critical for modulating coupling
conductance between the AII amacrine cells and ON cone bipolar
cells (Mills and Massey, 1995). The exact role and mechanism of
cGMP regulation in second and third order neurons is not clear.
In order to better understand the role of cGMP in different steps
of processing, and especially in ON bipolar cells, it is important to
localize PDE enzymes in retina. To this end, using our ON bipo-
lar cell cDNA library, we identified a PDE isoform PDE9A and
determined that these cells express the transcript for this isoform
(Dhingra et al., 2008). Moreover analysis of the retinal transcrip-
tome database (Siegert et al., 2009) showed that several amacrine
and ganglion cell types also express PDE9A transcripts. Because
PDE9A is expressed predominately in neurons (van Staveren and
Markerink-van Ittersum, 2005), and hydrolyses cGMPwith a very
low Km (Fisher et al., 1998), it likely contributes to retinal func-
tion. Here, using PDE9A−/− (KO) mouse, we report that PDE9A
contributes to the normal kinetics of the photopic electroretino-
gram (ERG). PDE9A is localized to amacrine cells, ganglion cells,
and to the ciliary body, but not ON bipolar cells. We therefore
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conclude that inner retinal expression of PDE9A in amacrine cells
contributes to response kinetics of the ERG b-wave.
MATERIALS AND METHODS
GENERATION OF PDE9A KNOCKOUT MICE
PDE9A−/− (KO) mice were obtained from Pfizer (Menniti et al.,
2008) and were initially generated by Deltagen (San Mateo, CA).
Briefly, a targeting construct with neomycin resistance (neo) and
bacterial LacZ (coding for β-galactosidase or β-gal) genes was
designed to disrupt the PDE9A gene (Accession # AF031147) in
ES cells by homologous recombination. The resultant allele had
a replacement of part of exon 11/12 of PDE9A with neo-LacZ
cassette that shifted the downstream sequence out of the open
reading frame. The ES cells were injected into blastocysts and the
resulting chimeras were tested for germ line transmission. The
following primers were used for genotyping:
GS (E) (CACAGATGATGTACAGTATGGTCTGG);
GS (T,E) (TGCAGTCATCAGGACCAAGATGTCC); and
Neo (T) (GACGAGTTCTTCTGAGGGGATCGATC).
Genotyping was performed on tail DNA using a multiplex PCR
reaction: GS (T, E) + Neo (T) for targeted allele (expected size
599 bp); GS (E) + GS (T, E) for endogenous allele (expected
size 256 bp). KO mice were bred to homogenicity by multiple
back-crossings (>6) with C57BL6/J mates. Mouse colonies were
maintained by breeding KO mice; no specific behavioral phe-
notypes were observed in these mice. Age matched C57BL6/J
(WT) were purchased from Jackson Labs (Bar Harbor, Maine).
All experiments were done in compliance with federal regu-
lations and the protocol was reviewed and approved by the
Institutional Animal Care and Use Committee of the University
of Pennsylvania. Both male and female mice were used for all
experiments.
ELECTRORETINOGRAM
The ERG recording setup and methods have been described
elaborately (Lyubarsky et al., 1999, 2000; Ng et al., 2010). In
short, mice were dark-adapted, deeply anesthetized intraperi-
toneally under dim light with ketamine/xylazine/urethane (20, 8,
and 800μg/gm bodyweight, respectively) and were placed on a
platform maintained at 37–38◦C. Pupils were dilated with 1%
tropicamide saline solution (Mydriacyl, Alconox). A platinum
electrode was inserted into the mouth to serve as a reference
and ground electrode, and another platinum electrode was placed
on the cornea. Mice were placed inside a light-proof Ganzfield
Faraday cage. ERG recordings from KO and age matched WT
mice were performed on the same day under identical settings
and conditions. Light stimuli were either 4ms flashes produced
by a light-emitting diode (LED) stimulator or <1ms flashes
produced by a Xenon tube delivered in the Ganzfeld (Espion
Electrophysiology System; Diagnosys). For scotopic ERG, inten-
sities of light flashes were converted to the estimated number
of photoisomerizations (R∗) per rod as described previously
(Lyubarsky et al., 2004). For photopic ERG, light intensity was
converted to number of photons per μm2 at the cornea as
described previously (Lyubarsky et al., 1999, 2000). For pho-
topic stimuli, a rod-suppressing step of light (30 scot cd m−2)
was given every 5.5 s and a light flash was superimposed on it 2 s
after the onset of the step. ERGs were recorded from both eyes
using differential amplifiers with a bandwidth of 0.1Hz–1 kHz,
and a sampling interval of 1ms. Depending on the signal-
to-noise ratio, each record was an average of 3–25 individual
trials.
The various parameters characterizing the ERG waveform
were determined using a user-defined MATLAB® (Mathworks,
MA) program. The amplitude of the b-wave was quantified by
subtracting the peak of the a-wave from the peak of the b-wave.
The functional characteristics of phototransduction in photore-
ceptors in WT and KO animals were determined from the ERG
a-wave by fitting the rising phase of the a-wave with the transduc-
tion cascade activation model (Breton et al., 1994; Lyubarsky and
Pugh, 1996) as follows:
F(t) = exp[−0.5A (t − teff
)2], (1)
where F(t) is the a-wave amplitude at time t after a brief flash
normalized to the saturated amplitude;  is the number of pho-
toisomerizations per rod; teff a brief delay; A is the amplification
constant whose value is estimated by the best fit. ERG data pre-
sented in this paper were performed on 12 WT and 14 KO mice,
but occasional records were too noisy and were not considered.
Values of the measured response parameters for the left and right
eyes were averaged and treated as a single data point. The number
of animals or data points acquired for each stimulus condition
is specified in the Results section. All data values in the figures
are presented as mean ± s.e.m. Unless stated otherwise, statisti-
cal comparison of a parameter between groups of WT and KO
was performed using two-tailed Student’s t-test. A p-value of less
than 0.05 (p < 0.05) was considered significant and p < 0.01 was
considered highly significant.
β-GALACTOSIDASE ASSAY
Mice were deeply anesthetized with an intraperitoneal injec-
tion of ketamine and xylazine (100 and 10μg/gm bodyweight).
Eyes were enucleated and incised just below the limbus. Eyeballs
were fixed in 4% paraformaldehyde for 10min, and rinsed in
0.1M phosphate buffer. For cryosections, eyeballs were cry-
oprotected by soaking overnight at 4◦C in 0.1M phosphate
buffer containing 30% sucrose and embedded in a mixture
of two parts 20% sucrose in phosphate buffer and one part
optimal cutting temperature compound (Tissue Tek, Electron
Microscopy Sciences, Hatfield, PA, USA). Radial sections (15–
20μm) were cut on a cryostat (Leica) at −20◦C and collected
on superfrost plus slides (Fisher Scientific, Pittsburgh, PA, USA).
β-galactosidase expression was detected enzymatically using X-
gal (5-bromo-3-indoyl-b-D-galactopyranoside stock solution) as
substrate. Briefly, whole mount or retinal sections were pre-
incubated in a detergent buffer (0.02% Nonidet P-40, 0.01%
Sodium Deoxycholate, and 2mM MgCl2 in 0.1M phosphate
buffer, pH 7.3) for about 10mins at room temperature (RT),
incubated for 2–4 days in staining buffer (0.02% Nonidet P-
40, 0.01% Sodium Deoxycholate, 5mM Potassium Ferricyanide,
5mM Potassium Ferrocyanide, and 2mM MgCl2 in 0.1M phos-
phate buffer, pH 7.3 containing 1–1.5mg/ml X-gal) and finally
rinsed twice in detergent buffer (5min each).
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IMMUNOFLUORESCENCE
Sections were permeabilized and blocked with 10% normal goat
serum, 5% sucrose and 0.5%Triton X-100 in phosphate buffer for
1 h at RT. Sections were incubated in primary antibodies (diluted
in blocking solution) at 4◦C overnight or occasionally for 3 days.
Primary antibodies were washed 3 times in 5% sucrose in phos-
phate buffer at RT. Sections were then incubated in secondary
antibodies at RT for 3 h, washed, mounted with Vectashield
mounting medium (Vector Laboratories, Burlingame, CA, USA)
and coverslipped. To identify X-gal-stained cells in the inner
retina, some retinal sections were first stained for GABA and then
processed for X-gal staining, and others were first processed for
X-gal staining, and then immunostained for GABA. For double
staining on the whole mount, we first stained for GABA overnight
and then with x-gal for at least 3 days; after imaging, the retinas
were also stained with DAPI. To avoid collapse of retinal layers,
retinas weremounted between number 0 cover slips, which served
to support the coverslip. The blue staining corresponding to the
sites of β-galactosidase activity and the fluorescent stainings were
examined with a conventional microscope (Nikon Eclipse TE-300
microscope; Nikon Inc., Melville, NY, USA).
Antibodies
Rabbit anti-PDE9A (1:100–500, GTX14625 fromGenetex, Irvine,
CA); rabbit anti-PDE9A (1:100, PD9A-101AP from FabGennix,
Frisco, TX); guinea-pig anti-GABA (1:1000, AB175, Chemicon
International, Temecula, CA); mouse anti-β-gal antibodies (a
monoclonal; 1:200, Promega, Madison, WI); and chicken anti-β-
gal (1:500, Aves labs Inc., Tigard, Oregon).
RESULTS
ABSENCE OF PDE9A DOES NOT AFFECT THE SCOTOPIC ERG, BUT
DECREASES THE AMPLITUDE OF THE ROD/CONE-GENERATED ERG
a-WAVE
To determine if PDE9A contributes to visual processing, we
recorded ERGs from WT and PDE9A KO mice. We first pre-
sented a series of scotopic flash intensities under dark-adapted
conditions and measured the amplitude of the b-wave. There was
no significant difference in the ERG b-wave amplitude between
KO and WT (Figures 1A–C). To assess the response kinetics,
we measured the time it took the b-wave to rise to 66% of
its peak amplitude, the time it took to fall to 66% of its peak
amplitude, and the 66% maximum width (as in Figure 1D).
We also analyzed the half width; however, because responses
of dark-adapted mice at high intensities often do not return
to baseline in the sampled duration of 500ms, this measure is
less reliable and is not reported here. Under scotopic condi-
tions, the kinetic parameters of KO and WT ERGs were similar
(Figure 1E).
Next, to determine the possible contribution of PDE9A to
the a-wave, we presented strong saturating flashes that stimulate
both rods and cones (Figure 2A). In response to the strongest
flash (I = 9.3 × 105 R∗/rod), both the a- and b-wave amplitudes
were significantly lower in KO than in WT. The a-wave saturating
amplitude in KO (227μV) was 36% lower than in WT (357μV;
p = 0.002), and the b-wave saturating amplitude of KO was 30%
lower (411μV in KO vs. 601 in WT; p = 0.009; Figure 2B). The
FIGURE 1 | PDE9A does not contribute to the ERG under scotopic
conditions. For all figures, WT is drawn in black and KO in red. Also for all
figures, data are plotted as average ±s.e.m. When the s.e.m. cannot be
seen, it is smaller than the symbol. (A,B) Representative responses to
increasing light intensities (0.2– 600 R∗/rod) from age matched WT (A) and
PDE9A KO (B) retinas. (C) Average b-wave amplitudes vs. flash intensity for
WT (black squares; 16–22 records) and KO (red diamonds; 18–28 records)
mice. (D) Illustration of the parameters used to characterize the kinetics of
the b-wave. Stimulus onset is designated by an upward black arrow, 66% of
the peak amplitude is indicated by the blue line and 50% by the green line.
Time taken by the b-wave to rise from the stimulus onset to 66% of its
peak amplitude (left dashed blue arrow) or to 50% of its amplitude (left
dashed green arrow) were used for comparison of its kinetics. Time taken
by the b-wave to fall to 66 or 50% of its peak amplitude is indicated by the
right blue and green arrows. (E) Times taken by the b-wave to rise
(triangles) and fall (squares) to 66% of its amplitude, and the duration
between them (width, circles) at the measured intensities.
ratios of b-wave to a-wave amplitude for the three intensities were
similar in KO and WT (ranged from 1.7 in WT and 1.8 in KO for
the lower intensity to 3.6 and 3.7 for the higher intensity).
To determine if the reduced a-wave was due to compromised
photoreceptor function, we computed the Lamb and Pugh ampli-
fication constant “A.” This constant provides a measure of the
gain of the photoreceptor transduction cascade that is indepen-
dent of light intensity for low-to-moderate intensities (Lyubarsky
and Pugh, 1996). The amplification constant A was computed by
fitting the a-wave component of two flash intensities (460 and
1860 R∗/rod) to Equation 1 (Figure 2C; the fit is shown with
dashed lines). The amplification constant A in WT (3.5) was not
statistically different from that in KO mice (4.3; Figure 2D; p =
0.11), indicating that deletion of PDE9A does not affect photo-
transduction. Next, we looked at the shape of the rod/cone mixed
response and computed the 66% maximum width. As expected,
in bothWT and KO, the rise time of the b-wave decreased slightly
and the fall time increased substantially with increasing inten-
sity. The curves of the rise time as a function of intensity for KO
and WT were very similar. The curves of the fall time and 66%
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FIGURE 2 | The amplitude of the a-wave is smaller in PDE9A KO but its
kinetics is largely unaffected. (A) Average response from WT and KO
retinas to a rod saturating flash (∼106 R∗/rod). (B) Average a-wave and
b-wave amplitudes (dark-adapted, rod and cone generated responses). Both
a-wave and b-wave amplitudes in KO (n = 14 mice for all intensities) are
significantly different from WT (n = 12) at the two highest intensities.
Unless otherwise stated, for all figures, “∗” designates p < 0.05 and
∗∗p < 0.01. (C) Expanded ERG responses from a KO and WT animal at the
flash intensities in (B) showing the a-waves and their Lamb and Pugh curve
fits (red and black dashed lines for KO and WT, respectively). The Lamb and
Pugh equation was fit to the average a-wave from both eyes of the animal
to estimate the amplification constant. (D) The Lamb and Pugh
amplification constants as estimated by regression in WT and KO animals
are similar. (E) The time taken by the b-wave to rise and fall to 66% of its
amplitude and the duration (width). For the highest intensity, the b-wave fell
to 66% of its amplitude only in 50% of WT and in 82% of KO.
maximum duration for KO crossed those of WT: at lower inten-
sities KOs were slightly faster, and at the highest intensity tested,
the KOs took longer to recover (Figure 2E). However, neither of
these differences was significantly different between WT and KO.
ABSENCE OF PDE9A SLOWS DOWN THE PHOTOPIC RESPONSE
To test the effect of deleting PDE9A on the photopic ERG wave,
we suppressed rod responses using a light step of 30 scotopic cd
m−2 and superimposed (in sequence, with 5.5 s delay between
trials) a saturating white flash of 1000 scot cd s m−2, UV flashes
(λ = 365 nm; 4 × 103, 8 × 103, and 1.65 × 104 photon/μm2),
green flashes (λ = 513 nm; 8 × 103, 1.6 × 104, and 3.2 × 104
photon/μm2) and another saturating white flash of 1000 scot cd
s m−2. In light-adapted rodents, the ERG a-wave is small and it
reflects the activity of cones and the OFF pathway; the b-wave pre-
dominantly reflects the activity of ON cone bipolar cells and to a
smaller extent that of the inner retina (Xu et al., 2003; Sharma
et al., 2005; Shirato et al., 2008). For the saturated flashes, the
average WT a-wave (combining the amplitude of both the first
and the last flash) was 37.3μV and in KO mice, it was 23.5μV;
significantly smaller than in WT (p = 0.004). The WT b-wave
(170μV) was larger than that of KO (137μV) by 20% (albeit not
significantly, p = 0.09; Figures 3A,B). Thus, absence of PDE9A
greatly reduced the photopic a-wave amplitude, and only mildly
effected the b-wave. Examination of the wave shape (Figure 3C)
showed that while the times for the b-wave to rise to 66% of
the peak in KO (40ms) were similar to those in WT (41ms)
(p = 0.56), the time it took the b-wave to fall to 66% of its peak
amplitude was highly significantly longer in KO (227 in KO vs.
156ms in WT; p = 0.0001). Consequently, the 66% maximum
width was also highly significantly longer in KO (201 in KO vs.
116ms in WT; p = 0.0001).
Because photopic ERG responses were slower in KO than in
WT, we wondered if light adaptation contributed to this differ-
ence. We therefore compared the first saturating response to the
last saturating response in each experiment. Recall that the last
saturating flash was presented after the UV and green flashes,
so the eyes were exposed to the adapting light step for 12min
longer (Figures 3D–F). In WT, the kinetics of the b-wave in the
first and last saturating flashes were similar, while in KO, the
second presentation of the saturating flash resulted in a slower
decay. The difference in the 66% maximum width was not signif-
icant (paired t-test; p = 0.1), but the 50%maximumwidth in KO
was significantly longer in the second saturating flash (p = 0.007;
Figure 3F). This suggests that PDE9A contributes to the kinetics
of the cone-generated response, and that this contributionmay be
affected by the state of light adaptation.
To see if the effect of PDE9A’s absence is specific to high inten-
sities, or perhaps to different cone pathways, we examined the
responses to low intensities of UV and green flashes. In response
to UV flashes, both a- and b-waves amplitudes were similar in KO
and WT (Figures 4A,B). However, in response to green flashes,
both a- and b-wave amplitudes were significantly smaller in KO
(Figures 4D,E). Like the saturating response, the time for the b-
wave to decay to 66% and the 66% maximum duration were
significantly longer for both wavelengths at all intensities (p <
0.01; Figures 4C,F). In addition, at these wavelengths, the time
to rise to 66% of the peak amplitude was also significantly longer
(p < 0.001). Consequently, the time to peak in KO for all inten-
sities at both wavelengths was also significantly longer. Taken
together, our ERG results suggest that the main effect of delet-
ing PDE9A is on the photopic ERG which reflects activity in the
cone pathways.
PDE9A IS LOCALIZED TO CELLS IN THE GANGLION AND AMACRINE
CELL LAYERS
To understand the mechanism by which PDE9A affects retinal
processing, it is essential to determine its cellular localization.
We initially attempted to localize PDE9A using two commer-
cial antibodies; both gave intense staining in several layers of
the retina. However, when the antibodies were applied to KO
retinas, the staining patterns were similar to those of WT, sug-
gesting that the antibodies cross-react with other proteins (not
shown). We similarly obtained non-specific bands using Western
blots with these antibodies. To get a reliable localization pat-
tern, we stained retinas for the reporter Lac-Z that replaced
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FIGURE 3 | Absence of PDE9A slows the falling phase of the b-wave of a
saturating flash under photopic conditions. (A) Average responses of WT
and KO retinas to a saturating flash (1000 scot cd s m−2) after 2 s light
adaptation. The responses to both the first and second saturating flashes
(presented before and after stimulation with UV and green light, respectively)
in each retina were averaged. (B) Response amplitudes of the a- and b-waves
at the saturating flash are reduced in KO (13 WT and 14 KO mice). (C) The
times taken by the b-wave to rise and fall to 66% of its amplitude and the
duration between them. (D,E) Average response of WT and KO retinas to the
first (1) and second (2) saturating flash. (F) The width of the b-wave at 50% of
its amplitude for the first (1) and second (2) saturating flashes increased
in KO.
PDE9A in KO. We first attempted to immunostain for β-gal,
but there was no specific staining; instead we used the X-gal
assay. In whole mount KO retinas, staining was present through-
out the ganglion cell layer (GCL) (Figures 5A,B). No staining
was found in WT, suggesting that this staining is specific and
is present only in cells that normally express PDE9A. We deter-
mined the percentage of PDE9A-expressing cells within the GCL
by co-staining the retina with DAPI. In a total GCL area of
150,000μm2 (3 retinas combined) we found 1844 somas of
which 28% were stained for X-gal. We also performed X-gal
staining on vertical cryosections of the retina. Most staining
was observed in cells of the GCL, but some staining was also
observed in the somas of amacrine cells in the inner nuclear layer
(Figure 5C).
Based on transcript presence and pharmacological block-
ing of certain PDE isoforms, it was suggested that retinal
pigment epithelium (RPE) expresses PDE9A (Diederen et al.,
2007). If so, absence of PDE9A from these cells may be
able to explain the slow b-wave. We have therefore examined
retinal cryosections that had RPE and choroid layers intact.
There was no X-gal staining in the RPE; however we observed
staining in the non-pigmented epithelium of the ciliary body
(Figure 5D), in certain unidentified cells in the sclera, and
in the lens (not shown). We further examined whole mounts
of the pigment epithelium layer, but did not observe any
staining.
To determine whether the cells in the GCL were amacrine or
ganglion cells, we immunostained the X-gal stained retina for the
amacrine cell markers GABA and glycine (Figure 6). Our anti-
body against glycine gave a high general background without
specific staining, so the analysis relied on staining for GABA. We
found that most X-gal-stained cells in the GCL were negative for
GABA (e.g., cells 2, 6, 8 in Figures 6A–C), but many were positive
(e.g., cells 1, 7). Similarly, in the inner nuclear layer, most X-
gal-stained cells were negative for GABA but some were positive.
To determine the percent of X-gal-stained cells that use GABA
and the percent of GABA-immunoreactive cells that express β-
gal, we co-stained whole mount retinas with X-gal and for GABA
(Figure 6D). We found that in the GCL, 20% of X-gal-stained
cells also stained for GABA, and 20% of GABAergic cells also
stained with X-gal (3 retinas, Table 1). In the INL, 27% of X-gal-
stained cells stained for GABA, but only 7% of the GABAergic
cells stained with X-gal. This experiment suggests that PDE9A is
present in one or more types of GABAergic amacrine cells, but
mostly in GABA-negative cells.
DISCUSSION
We report here on two main findings. First, within the retina,
PDE9A is restricted to the inner layers: it is widely distributed
within the GCL and less widely within the amacrine tier of the
inner nuclear layer. Second, PDE9A contributes to the amplitude
and kinetics of the photopic ERG.
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FIGURE 4 | PDE9A accelerates the kinetics of the photopic b-wave.
(A) Average responses from WT and KO retinas to ultra-violet (UV) light of
intensity 1.65 × 104 photonsμm−2 (17 records were averaged for WT and
24 for KO). (B) Amplitudes of the a- and b-waves from WT (n = 9–12 mice)
and KO (n = 12–13) retinas at increasing intensities of UV light. (C) The
time taken by the b-wave to rise and fall to 66% of its amplitude at
different intensities of stimulation. The time taken by the b-wave to rise
and decay to 66% of its amplitude was significantly longer in KO at all
intensities. (D) Average response of WT and KO retinas to green light of
intensity 3.2 × 104 photonsμm−2 (n = 16 for WT and 19 for KO).
(E) Amplitudes of the a- and b-waves from WT (n = 7–11) and KO
(n = 2–11). Mice at increasing intensities of green light. (F) The times
taken by the b-wave to rise and fall to 66% of its amplitude: both
parameters are significantly longer in KO.
FIGURE 5 | PDE9A is localized in the inner retina. (A) Low magnification
(4×) image of a whole mount PDE9A KO retina stained for X-gal (blue); on,
optic nerve head. (B) Higher magnification (40×) image of the ganglion cell
layer (GCL) in the same retina as in (A): the stained cells occupy less than
50% of the area. (C) A cryosection of a KO retina stained for X-gal. X-gal
staining is present in both the inner nuclear layer (INL) and GCL. IPL: inner
plexiform layer. (D) Cryosection of KO retina showing X-gal staining in the
ciliary body.
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FIGURE 6 | A population of X-gal positive cells is positive for GABA.
(A,B) Cryosections from KO retinas double stained with X-gal (A1,B1; blue,
visualized with DIC microscopy) and for GABA (A2,B2, visualized with
fluorescence microscopy). Dotted circles indicate the location of the somas
of the cells that are positive for X-gal. The merged images (A3,B3) show
that some cells positive for X-gal are also positive for GABA and others are
negative for GABA. (C) Magnified images of the X-gal positive cells
(numbers on the side correspond to numbers on the low magnification
images) that are also positive for GABA. Cells 1, 7 are located in the GCL
and cell 4 is located in the INL. (D) Whole mount preparations stained
with X-gal reagent and for GABA show that some cells in both GCL and
INL stained for both (circles), while several X-gal stained cells were
negative for GABA and numerous GABA-immunoreactive cells were not
stained with X-gal.
PDE9A IS LOCALIZED TO SEVERAL RETINAL CELL TYPES
Our experiments identify at least three retinal cell types that
express PDE9A: GABAergic amacrine cells, non-GABAergic
amacrine cells (hence, glycinergic), and ganglion cells. The
GABAergic amacrine cell type was identified by GABA-positive
staining in a subset of X-gal-stained cells. We know that our
immunostaining for GABA is genuine because we have previ-
ously shown that all cells that immunostain for GABA also express
GAD65 or GAD67 (Vardi and Auerbach, 1995). In the inner retina,
cGMP is predominantly synthesized by the soluble isoform of
guanylate cyclase (sGC), which is activated by nitric oxide (NO).
Immunostaining for the β1 subunit of sGC (the obligatory sub-
unit of the heterodimer in neurons) in rat retina shows that sGC
is expressed in a subset of amacrine cells, some of which are
GABAergic (Ding and Weinberg, 2007). Given that the retinas of
rats andmice are sufficiently similar, it is likely that these cells may
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Table 1 | Percentage of PDE9A-expressing cells in retina (averages of 3
retinas).
GCL INL
No. of X-gal-stained cells/206,000μm2 495 219
No. of GABA-stained cells 325 509
% of X-gal cells that use GABA 20% 27%
% of GABA cells that expresses X-gal 20% 7%
be the GABAergic PDE9A-expressing amacrine cells. It remains to
be determined whether the GABA-stained amacrine cells in the
GCL are of the same type as those in the INL (but displaced),
or if they represent a different amacrine cell type. The glyciner-
gic type is inferred because nearly all amacrine cells in the INL
stain either for GABA or for glycine (Marc et al., 1995; Vardi
and Auerbach, 1995; Kalloniatis et al., 1996), thus it is highly
likely that the GABA-negative X-gal stained amacrine cells are
glycinergic. This inference agrees with a previous report that NO-
stimulated cGMP production is localized to glycinergic amacrine
cells (Yu and Eldred, 2005). We think that one or more ganglion
cell types express PDE9A because of the following facts: (1) about
40% of the GCL cells are ganglion cells (Jeon et al., 1998); (2) only
few glycinergic amacrine cells are present in the GCL (Pourcho
and Goebel, 1985, 1987; Marc et al., 1995); and (3) the PDE9A-
expressing cells in the GCL are more numerous than those in
the INL, in fact about 30% of cells in GCL express PDE9A (this
study). This agrees with presence of PDE9A transcript in ganglion
cells (Siegert et al., 2009) and with reports that NO stimulates
production of cGMP in certain ganglion cells (Ahmad et al., 1994;
Blute et al., 2003).
PDE9A ACCELERATES THE PHOTOPIC ERG b-WAVE BY ENHANCING
SERIAL INHIBITORY RESPONSES
The most striking phenotype of deleting PDE9A is the change
in the kinetics of the photopic b-wave. Under light-adapted
conditions, at the tested UV, green, and saturating white light
intensities, the falling phase of the b-wave in KO was slower, and
the wave was wider than in WT. For UV and green flashes, the
rising phase of the b-wave was also slower. Slower ERG b-wave
in light-adapted conditions had been reported following intrav-
itreal injection of TTX in mouse (Miura et al., 2009) and rat
(Bui and Fortune, 2004; Mojumder et al., 2008). Similar effects
of TTX on ERG kinetics were also reported in rabbit after 5min
of dark adaptation (Dong and Hare, 2000). Even a greater effect
on the photpic ERG kinetics was found following injection of
PDA (cis-2, 3-piperidinedicarboxylic acid which blocks transmis-
sion to hyperpolarizing 2nd order and all 3rd order neurons), or
CNQX (Sharma et al., 2005; Miura et al., 2009). Another com-
mon qualitative outcome to the PDE9A KO and to applications
of TTX, PDA, or CNQX is the reduced b-wave amplitude. While
some of the effect of TTX in the light adapted retina is due to
sodium channels in certain ON cone bipolar cells (Mojumder
et al., 2008), an additional effect must be due to contribution from
the inner retina, suggesting that spiking amacrine cells enhance
and speed up the ON cone bipolar cells’ responses. The precise
mechanisms by which amacrine cells affect the b-wave are not
known. However, it is known that cone bipolar cells receive dif-
ferent types of inhibitory input from amacrine cells and that these
amacrine cells themselves receive inhibitory input (serial inhibi-
tion). Furthermore, it has been shown by whole cell recordings
and ERG recordings that these inhibitory circuits accelerate and
often enhance bipolar cells’ responses (e.g., Dong and Hare, 2000,
2002; Molnar and Werblin, 2007; Eggers and Lukasiewicz, 2011;
Eggers et al., 2013).
How can deletion of PDE9Amimic this effect? It is well known
that many amacrine cells use cGMP to modulate their activity.
For example, light stimulation increases NO levels in the IPL
(Eldred and Blute, 2005) and this increases the levels of cGMP.
NOS1 (the enzyme that produces NO in neurons) is expressed
in certain types of GABAergic amacrine cells, and NO stimu-
lates the production of cGMP in neighboring sGC expressing cells
(Ding and Weinberg, 2007). It is possible that these sGC express-
ing amacrine cells are those that express PDE9A, and that these
two enzymes regulate cGMP in a light-dependent manner. Since
cGMP activates cGMP-dependent kinases (such as PKG), and
since phosphorylation crucially controls exocytosis and endocy-
tosis (Liu, 1997), absence of PDE9A can alter neurotransmiter
release. Thus, if PDE9A-expressing cells inhibit bipolar cells in a
time-dependent manner to regulate their response size and kinet-
ics; absence of PDE9A, which likely causes an accumulation of
cGMP, would render bipolar cells’ responses slower. Based on the
characteristics of the b-wave seen in the absence of PDE9A and
their resemblance to the pharmacological results described above,
we predict that these cells spike at photopic intensities. Finally,
although PDE9A is likely present also in ganglion cells, we do
not think that they contribute to reducing the ERG b-wave and
slowing down its kinetics because in WT, ganglion cells do not
contribute to the ERG a- and b- waves (Bui and Fortune, 2004; Li
et al., 2005; Mojumder et al., 2008). Ganglion cells, however, do
contribute to the photopic negative response (PhNR) (Li et al.,
2005), and although not quantified here, this wave might have
been affected.
PDE9A LIKELY REDUCES THE CONE-GENERATED a-WAVE DUE TO AN
EFFECT ON THE OFF PATHWAY
We found that in the absence of PDE9A, the photopic a-wave
elicited by both green and saturating flashes was smaller. In
rodents, the photopic a-wave is generated by the activity of cones
and post-receptoral neurons, which includes a small contribution
from OFF bipolar cells and horizontal, and perhaps a larger con-
tribution from amacrine cells (Xu et al., 2003; Sharma et al., 2005;
Mojumder et al., 2008; Shirato et al., 2008). We think that the
reduced a-wave in KO represents reduced current contribution
from the inner retinal cells and not reduced cone activity because
cones do not express PDE9A. Thus, the same disrupted signal
processing that explains the reduced ON bipolar cells’ activity,
as reflected by the ERG b-wave in KO, could explain the reduced
inner retina component of the photopic a-wave (either an indi-
rect influence on OFF bipolar cells’ activity or reduced current
from amacrine cells). This interpretation also explains why the a-
wave of the mix rod-cone ERG was smaller in KO than in WT
retina. With such bright flashes, both cones and inner retinal cells
likely contribute to the negative a-wave. In contrast, rod function
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has not been altered, as can be inferred from both the similar
Lamb and Pugh amplification constants and the similar scotopic
responses in KO and WT.
CONCLUSION
The results of our study indicate that PDE9A, by hydrolyz-
ing cGMP, controls its levels and thereby modulates inhibitory
processes in the retina. We speculate that light increases nitric
oxide levels in the cone pathway of the inner retina; this stimu-
lates sGCs, increases cGMP levels, and modulates inhibition. By
hydrolyzing cGMP, PDE9A restricts the duration of the inhibitory
processes, thus sharpening and accelerating retinal signaling.
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